Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More
Xconomy
JUNE 14, 2019
Is one of the bigger biopharma acquisitions of the year in trouble? The US Federal Trade Commission wants yet more information about the buyout, and overseas, the UK Competition and Markets Authority opened a separate investigation. This past week, antitrust regulators once again delayed Roche’s planned $4.8
Let's personalize your content